Meridian Bioscience receives U.S. FDA Emergency Use Authorization for Revogene SARS-CoV-2 molecular assay
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
The company expects to begin shipping this product before the end of its fiscal first quarter, ending December 31, 2021
The ground-breaking project, led by Genomics England and NHS England, was established in 2013 to sequence 100,000 whole genomes from NHS patients and their families
A final decision regarding the approval of Ronapreve is expected from the European Commission shortly
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
The consideration for the acquisition is US $ 2.25 million
It was recognized for its holistic initiatives designed to improve the quality of life and standards of care for patients
The workshop had been organized by the department of surgery at Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU), along with the Association of Surgeons of Aligarh (ASA)
The new facility will provide an important boost to vaccine capacity in Africa
In the overall study population through Day 28, no deaths were reported in patients who received Paxlovid as compared to 10 deaths in patients who received placebo
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
Subscribe To Our Newsletter & Stay Updated